Clin2
NCT06772753Possibly a fitRecruiting

Study of Psychedelic Effects in Healthy Adults

Psychedelic Effects in Healthy Volunteers

Treatments studied

This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
25 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 25 and 55 years old.
  • Your BMI (body mass index) must be between 18 and 34.
  • You need to be in good general health, with no major heart problems, epilepsy, or insulin-dependent diabetes.
  • You must stop taking any recreational drugs (including alcohol) for 24 hours before each session, but coffee and nicotine are okay.
  • You cannot be pregnant, nursing, or have a history of severe substance use disorder.
  • You must not have a family history of certain mental health conditions like schizophrenia or bipolar I disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07565493Recruiting· Early Phase 1
Psilocybin with a serotonin blocker in healthy adults

This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.

Baltimore, Maryland
NCT05301608Recruiting· Phase 1/Phase 2
Psilocybin study of brain activity and changing thoughts

This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.

Baltimore, Maryland
NCT07180108Enrolling by invitation· Phase 1
Psilocybin and music study for healthy volunteers

This study tests how music affects your experience with psilocybin, a psychedelic substance. It may help researchers understand how to create the best setting for psilocybin therapy.

Baltimore, Maryland
NCT07433452Not yet recruiting· Phase 1
Psilocybin study in healthy volunteers with psychedelic interest

This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.

NCT06899334Recruiting· Phase 1
Comparing LSD, psilocybin, and DMT in healthy volunteers

This study compares how three different psychedelic substances affect your state of mind. The goal is to better understand these altered states, which may help develop future treatments.

Basel
NCT07386730Recruiting· Phase 1
Psychedelic therapy study for older adults with low well-being

This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.

San Francisco, California

Hear when a new Psychedelic Effects in Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.